# Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

> **NCT01963195** · PHASE2 · UNKNOWN · sponsor: **Anhui Medical University** · enrollment: 30 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Icotinib

## Key facts

- **NCT ID:** NCT01963195
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01963195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01963195, "Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT01963195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*